Gleb S. Ivanov

1.1k citations
11 papers · 855 indexed · 1 hit paper · h-index 5
Topics
Cancer-related Molecular Pathways (3 papers)DNA and Nucleic Acid Chemistry (2 papers)Epigenetics and DNA Methylation (2 papers)

In The Last Decade

Gleb S. Ivanov

10 papers receiving 847 citations

Hit Papers

Regulation of p53 activity through lysine methylation20042026201120182004200400600

Peers

Gleb S. Ivanov
Comparison fields: 5 of 75
  • Molecular Biology 770
  • Oncology 246
  • Cancer Research 64
  • Genetics 47
  • Biotechnology 29
Replace Uta-Maria Bauer with:
Uta-Maria Bauer Germany
Thang Van Nguyen United States
Gaofeng Cui United States
Elodie Hatchi France
Rohrmoser Michaela Germany
Svetlana Stoykova United States
Ou Li United States
Roberto Dal Zuffo Italy
Ki Sa Sung South Korea
Andrew Zupnick United States
Gleb S. Ivanov relative to Uta-Maria Bauer Germany Uta-Maria Bauer's profile →
Citations per field
00.5×1.5×2.2×
Uta-Maria Bauer · 1×
Citations per year

Countries citing papers authored by Gleb S. Ivanov

Since Specialization
Citations

This map shows the geographic impact of Gleb S. Ivanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gleb S. Ivanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gleb S. Ivanov more than expected).

Fields of papers citing papers by Gleb S. Ivanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gleb S. Ivanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gleb S. Ivanov. The network helps show where Gleb S. Ivanov may publish in the future.

Co-authorship network of co-authors of Gleb S. Ivanov

This figure shows the co-authorship network connecting the top 25 collaborators of Gleb S. Ivanov. A scholar is included among the top collaborators of Gleb S. Ivanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gleb S. Ivanov. Gleb S. Ivanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 4
2 11
3 12
4
[NEGATIVE REGULATORS OF TUMOR SUPPRESSOR P53 IN THE CONTEXT OF ANTICANCER THERAPY].
2
5
Aleukemic leukemia cutis
2
6 158
7 3
8
Regulation of p53 activity through lysine methylationbreakdown →
656
9 4
10
[Structure of illexine I2 and its complexes with DNA].
3
11
[Comparative study of synthetic peptide fragments of histones H2B].
0

About Gleb S. Ivanov

Gleb S. Ivanov is a scholar working on Pharmaceutical Science, Biotechnology and Oncology, having authored 11 papers that have together received 855 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), DNA and Nucleic Acid Chemistry (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Molecular Biology (770 citations), Oncology (246 citations) and Aging (10 citations). Gleb S. Ivanov has collaborated with scholars based in United States, Russia and United Kingdom. Frequent co-authors include Julia K. Kurash, Danny Reinberg, Nickolai A. Barlev, N. Justin, J. Wilson, Carol Prives, Paul Tempst, Bing Xiao, Kristine McKinney and Sergei Chuikov. Their work appears in journals such as Nature, Molecular and Cellular Biology and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026